Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy.
atrial fibrillation episode
intracardiac electrocardiogram
Journal
Archives of medical science : AMS
ISSN: 1734-1922
Titre abrégé: Arch Med Sci
Pays: Poland
ID NLM: 101258257
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
10
2019
accepted:
01
12
2019
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
Implantable cardioverter defibrillators register various types of arrhythmias. Thus they can be exploited to better identify patients with atrial fibrillation episodes and increase the proportion of patients who may benefit from implementation of pharmacological prophylaxis of thromboembolic events, most of which are asymptomatic. The aim of the study was to assess of the frequency, symptoms and predisposing factors for the occurrence of atrial fibrillation episodes in patients with an implanted implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy with defibrillator (CRT-D) based on the analysis of intracardiac electrocardiograms (EGM/IEGM) records. The study included 174 consecutive outpatients with heart failure, sinus rhythm and an implanted cardioverter defibrillator and cardiac resynchronisation therapy with defibrillator. Follow-up visits with analysis of IEGM records occurred every 3 months. During a mean follow-up of 20 months, 901 visits were carried out. One hundred forty-seven patients had at least 1 year of follow-up. Atrial fibrillation episodes in the study group occurred in 54 (31.0%) patients and 71.4% were asymptomatic. Predisposing factors were: history of paroxysmal atrial fibrillation (37.0% vs. 13.3%, Episodes of paroxysmal atrial fibrillation in patients with systolic heart failure and implanted cardioverter-defibrillator systems are quite common. The majority of the episodes recorded in the study were asymptomatic.
Identifiants
pubmed: 34900037
doi: 10.5114/aoms/114977
pii: 114977
pmc: PMC8641502
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1583-1589Informations de copyright
Copyright: © 2021 Termedia & Banach.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Circulation. 1981 Jan;63(1):80-6
pubmed: 7438410
Eur Heart J. 2017 May 1;38(17):1339-1344
pubmed: 28329139
Am J Cardiol. 2015 Sep 15;116(6):889-93
pubmed: 26183793
Am J Cardiol. 2019 Feb 15;123(4):592-597
pubmed: 30527775
Int J Clin Pract. 2014 Apr;68(4):444-52
pubmed: 24499075
Am Heart J. 2017 Aug;190:19-24
pubmed: 28760209
Vascul Pharmacol. 2016 Aug;83:26-35
pubmed: 27196706
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
Arch Med Sci. 2019 Jul;15(4):845-856
pubmed: 31360179
Arch Med Sci. 2019 May;15(3):632-640
pubmed: 31110528
J Am Coll Cardiol. 2004 Jan 7;43(1):47-52
pubmed: 14715182
Eur Heart J. 1997 Mar;18(3):507-13
pubmed: 9076390
Arch Med Sci. 2019 Mar;15(2):385-392
pubmed: 30899291
J Am Coll Cardiol. 2008 Jun 3;51(22):2153-60
pubmed: 18510963
Circ Arrhythm Electrophysiol. 2008 Aug;1(3):184-92
pubmed: 19808412
Eur J Echocardiogr. 2010 May;11(4):307-32
pubmed: 20435783
Cardiol J. 2013;20(4):364-9
pubmed: 23913454
Arch Med Sci. 2018 Jun;14(4):890-909
pubmed: 30002709
Eur Heart J. 2018 Apr 21;39(16):1407-1415
pubmed: 29340587
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
J Am Coll Cardiol. 2001 Nov 1;38(5):1585-6
pubmed: 11691547